GSK takes bids in European consumer-drug sale

GlaxoSmithKline ($GSK) is steaming ahead with its sale of consumer-drug brands. After unloading U.S. rights to a basket of products last year, the company accepted bids for European rights from private equity players and rival drugmakers. The sale could bring in £500 million, sources said. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.